- Strategy
- Payers
- AI
- Cybersecurity
- Device Development
- Studies/Published Research
- Ethics
- Regulatory
- Digital Biomarkers
- Data Science
- Companion Diagnostics
- Clinical Care
- Digital Therapeutics
- Academic Research
- Virtual Reality
- RWE
- Digital Endpoints
- Medical Devices (Class II and Class III)
- Commercialization
- Clinical Trials
- Drug-Device Combinations
- SaMD
- Remote Patient Monitoring
- Patient Engagement
- Profiles/Q&A
Swing Selects Curavit to Provide Virtual Trial Site Services for Fibromyalgia
Curavit Clinical Research has been selected by Swing Therapeutics to be a virtual site for its trial on investigating digital therapeutics (DTx) for fibromyalgia. Curavit will remotely be conducting the study, recruiting participants virtually from across the United States, to participate in a 12-week RCT. Curavit with Swing will prioritize patient recruitment through virtual services where patients may feel less burdened and be more likely to stay with the duration of the trial.
Read more about this news release here.
Aspirin-Free Regimen Lowers Bleeding Events in Patients With Heartmate 3 Heart Pump
December 14th 2023Patients with the HeartMate 3 heart pump for advanced heart failure not taking aspirin as part of their blood-thinning medication regimen had fewer complications from bleeding with lower hospital visits.
